Amgen (AMGN) Construction in Progress (2009 - 2022)

Amgen (AMGN) has reported Construction in Progress for 14 consecutive years, with $1.2 billion the latest figure, recorded in Q4 2022.

• In Q4 2022, Construction in Progress rose 22.9% year-over-year to $1.2 billion; the TTM figure through Dec 2022 stood at $1.2 billion (up 22.9% YoY), while the FY2022 annual figure was $1.2 billion, up 22.9% from the prior year.
• Construction in Progress came in at $1.2 billion for Q4 2022 at Amgen, up from $987.0 million in the prior quarter.
• The five-year high for Construction in Progress was $1.2 billion in Q4 2022, with the low at $907.0 million in Q4 2019.
• Average Construction in Progress over 5 years is $995.0 million, with a median of $953.0 million recorded in 2018.
• Across the five-year window, Construction in Progress declined 4.83% in 2019 and climbed 22.9% in 2022, its largest moves.
• Year by year, Construction in Progress stood at $953.0 million in 2018, then fell by 4.83% to $907.0 million in 2019, then increased by 0.88% to $915.0 million in 2020, then advanced by 7.87% to $987.0 million in 2021, then gained by 22.9% to $1.2 billion in 2022.
• According to Business Quant data, Construction in Progress over the past three periods registered $1.2 billion, $987.0 million, and $915.0 million for Q4 2022, Q4 2021, and Q4 2020 respectively.